Samsung BioLogics loses $6 billion in stocks dive after notice of accounting breach

SEOUL (Reuters) - Shares in Samsung BioLogics Co Ltd tumbled nearly 20 percent on Wednesday, losing almost $6 billion in value in their biggest daily intra-day fall, after South Korea's financial watchdog provisionally decided it had breached an accounting rule.

from Reuters: Health News https://ift.tt/2FyV8e6